TherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of TherapeuticsMD (NASDAQ:TXMD) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the stock.

TherapeuticsMD Stock Performance

TXMD stock opened at $1.39 on Tuesday. The company’s 50 day moving average price is $0.95 and its 200 day moving average price is $1.15. TherapeuticsMD has a fifty-two week low of $0.70 and a fifty-two week high of $2.44.

TherapeuticsMD Company Profile

TherapeuticsMD, Inc operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors.